GlassScriptPhysician profile
Dale Levy
NPI 1487639043
$2,666.72
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2020: $361 · 2021: $471 · 2022: $582 · 2023: $199 · 2024: $32.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $828.95 | 2019 | |
| Medtronic, INC. | $423.61 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $357.92 | 2019-2023 | Epic |
| Atricure, INC. | $346.54 | 2021-2022 | |
| Edwards Lifesciences Corporation | $163.53 | 2020-2023 | |
| Getinge USA Sales, LLC | $122.51 | 2021 | |
| Medtronic Vascular, INC. | $122.45 | 2020 | |
| Abiomed | $101.67 | 2021 | |
| Bard Peripheral Vascular, INC. | $41.03 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.35 | 2021-2023 | Lifevest |
| Elutia, INC. | $23.12 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $22.30 | 2022 | |
| Amgen INC. | $21.72 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.67 | 2019 | |
| Melinta Therapeutics, LLC | $16.42 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Technology INC | $15.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.